Fig. 1From: Impact of PCSK9 inhibitors in glycaemic control and new-onset diabetesIncidence (%/year) of new onset Diabetes Mellitus according to their original groupPCSK9iG: PCSK9i users; PSMG: Propensity score matching group (control group 1); D@G: di@bet.es cohort (control group 2); FH: familial hypercholesterolemia groupBack to article page